Medicare Enrolled

Dr. Michael Weinblatt, MD

Rheumatology · Boston, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
75 FRANCIS ST, Boston, MA 02115
6177325325
In practice since 2006 (19 years)
NPI: 1487768081 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weinblatt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weinblatt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weinblatt

Dr. Michael Weinblatt is a rheumatology specialist in Boston, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Weinblatt performed 540 Medicare services across 317 unique beneficiaries.

Between the years covered by Open Payments, Dr. Weinblatt received a total of $313,349 from 34 pharmaceutical and/or device companies across 254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weinblatt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 40% volume in MA $313,349 industry payments

Medicare Practice Summary

Medicare Utilization ↗
540
Medicare services
Top 40% in MA for rheumatology
317
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~28 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 352 $76 $404
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 173 $51 $275
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
 15 $61 $371
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$313,349
Total received (2018-2024)
Avg $44,764/year across 7 years
Top 1% in MA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
254
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$276,518 (88.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$33,542 (10.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,289 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,244
2023
$26,113
2022
$39,777
2021
$48,374
2020
$52,970
2019
$48,586
2018
$95,286

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Eli Lilly and Company
$888
Roche Products Limited
$575
Gilead Sciences, Inc.
$500
UCB, Inc.
$179
Sandoz Inc.
$54
Novartis Pharmaceuticals Corporation
$35
PFIZER INC.
$13
Top 3 companies account for 87.5% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$57,535
Eli Lilly and Company
$48,777
PFIZER INC.
$41,001
Gilead Sciences, Inc.
$29,966
Incyte Corporation
$22,800
WHITEHALL INTERNATIONAL INC
$18,500
GlaxoSmithKline, LLC.
$16,593
AbbVie, Inc.
$13,881
Horizon Therapeutics plc
$8,902
SANOFI US SERVICES INC.
$7,176
AbbVie Inc.
$6,790
Janssen Biotech, Inc.
$5,225
Horizon Pharma plc
$5,000
Amgen Inc.
$4,193
SANOFI-AVENTIS U.S. LLC
$4,186
F. Hoffmann-La Roche AG
$4,153
UCB SA
$3,300
Kiniksa Pharmaceuticals, Ltd.
$3,000
ABBVIE INC.
$1,845
Lilly USA, LLC
$1,820
Genentech, Inc.
$1,320
Fresenius Kabi USA, LLC
$1,300
Samsung Bioepis Co., Ltd.
$1,265
Janssen Research & Development, LLC
$1,100
Organon LLC
$868
Cumberland Pharmaceuticals, Inc.
$750
Roche Products Limited
$575
Novartis Pharmaceuticals Corporation
$430
Vertex Pharmaceuticals Incorporated
$347
UCB, Inc.
$259
NOVARTIS PHARMACEUTICALS CORPORATION
$226
Regeneron Healthcare Solutions, Inc.
$126
GENZYME CORPORATION
$84
Sandoz Inc.
$54
Top 3 companies account for 47.0% of all-time payments
Associated products mentioned in payments ›
Bimzelx · COSENTYX · Cimzia · Enbrel · HADLIMA · HYRIMOZ · Humira · ILARIS · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Non-Covered Product · ORENCIA · REDITREX · RENFLEXIS · RINVOQ · Rinvoq · SHINGRIX · TALTZ · TREMFYA · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (88%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for rheumatology in MA.

Looking for a rheumatology specialist in Boston?
Compare rheumatologists in the Boston area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
163
Per 100K population
20.8
County median income
$92,859
Nearest hospital
BRIGHAM AND WOMEN'S HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Weinblatt is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 1% of MA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Weinblatt experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Weinblatt performed 352 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weinblatt receive payments from pharmaceutical companies?
Yes. Dr. Weinblatt received a total of $313,349 from 34 companies across 254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weinblatt's costs compare to other rheumatologists in Boston?
Dr. Weinblatt's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weinblatt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologists in Boston
Browse rheumatologists in Boston ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in MA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in MA
Which MA rheumatologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Eli Lilly and Company Payments to Doctors
See all physicians who received payments from Eli Lilly and Company.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →